More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$12.99B
EPS
7.4
P/E ratio
59.9
Price to sales
1.61
Dividend yield
--
Beta
1.201
Previous close
$173.94
Today's open
$175.01
Day's range
$169.44 - $177.50
52 week range
$66.57 - $203.91
show more
CEO
Barry Balfe
Employees
39800
Headquarters
Dublin 18,
Exchange
Nasdaq Global Select
Shares outstanding
76567325
Issue type
American Depository Receipt
Healthcare
Biotechnology & Life Sciences
Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?
Icon PLC (ICLR) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research • Aug 28, 2026

Oakmark Concentrated Strategy Q2 2026 Performance Review
The portfolio's return was 9.21% (net) for the reporting period. Centene, ICON and Keurig Dr Pepper were the contributors during the quarter. Intercontinental Exchange, Salesforce and ConocoPhillips were the detractors during the quarter.
Seeking Alpha • Aug 11, 2026

Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist?
ICLR's discounted valuation and $23.4B backlog support upside potential, but falling estimates, weaker margins and execution risks argue for patience.
Zacks Investment Research • Aug 6, 2026

ICLR Jumps 33.2% in Three Months as Recovery Expectations Strengthen
ICON's 33.2% rally is backed by stronger proposal flow, bookings and backlog, but weaker earnings and margins cloud the recovery.
Zacks Investment Research • Aug 5, 2026

ICON Announces Private Offering of Notes
DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR) (“ICON”), a world-leading clinical research organization, announced today that its wholly-owned subsidiary, ICON Investments Six Designated Activity Company (the “Issuer”), intends to offer one or more series of senior notes (the “Notes”), in a private offering (the “Offering”) with registration rights, subject to market and other conditions. The Notes will be guaranteed on a senior unsecured basis by ICON.
Business Wire • Aug 4, 2026

ICON Announces Results of Annual General Meeting
DUBLIN--(BUSINESS WIRE)--ICON Announces Results of Annual General Meeting.
Business Wire • Jul 31, 2026

Icon Q2 Earnings Call Highlights
Icon NASDAQ: ICLR reported second-quarter 2026 revenue growth and strong bookings as higher pass-through activity supported the top line, while the company continued to manage business-mix pressures affecting reported margins.
MarketBeat • Jul 30, 2026

ICON Public Limited Company (ICLR) Q2 2026 Earnings Call Transcript
ICON Public Limited Company (ICLR) Q2 2026 Earnings Call Transcript
Seeking Alpha • Jul 30, 2026

ICON Reports Second Quarter 2026 Results
DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today reported its financial results for the second quarter ended June 30, 2026.
Business Wire • Jul 29, 2026

Icon PLC (ICLR) Lags Q2 Earnings Estimates
Icon PLC (ICLR) came out with quarterly earnings of $2.56 per share, missing the Zacks Consensus Estimate of $2.57 per share. This compares to earnings of $3.26 per share a year ago.
Zacks Investment Research • Jul 30, 2026

¹ Disclosures

Open an M1 investment account to buy and sell ICON plc commission-free¹. Build wealth for the long term using automated trading and transfers.